This invention gives novel methods to synthesize PPAR-gamma sparing compounds, like thiazolidinediones, useful in preventing/treating metabolic disorders, hypertension, obesity, diabetes, or inflammatory diseases. This evidence concerns the gene PPARG and obesity due to melanocortin 4 receptor deficiency.